Lloyd Mitchell Segal, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 140 shares at $85.45 ($12K) on 2013-06-14, disclosed to the SEC on 2013-06-18.
Open-market purchase of $12k VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| RPTX | SELL | 2024-03-27 | $37K | — | Filing → |
| RPTX | SELL | 2021-06-30 | $110K | — | Filing → |
| RPTX | SELL | 2021-06-10 | $55K | — | Filing → |